The Challenges Ahead for Exosomes Treatment for Diabetes Mellitus [Letter]

Zihang Feng1 Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China

Wenxia Lu2 Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China

Yu Xie3 Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]

References

Ashrafizadeh MKA, Aref AR, Zarrabi A, Mostafavi E, Mostafavi E. Exosomes as promising nanostructures in diabetes mellitus: from insulin sensitivity to ameliorating diabetic complications. Int J Nanomedicine. 2022;17:1229–1253. doi:10.2147/IJN.S350250
PubMed Web of Science ®Google Scholar
Marbán E. The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol. 2018;71:193–200. doi:10.1016/j.jacc.2017.11.013
PubMed Web of Science ®Google Scholar
Main H, Munsie M, O’Connor MD. Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clin Transl Med. 2014;3:10. doi:10.1186/2001-1326-3-10
PubMedGoogle Scholar
Chen J, Li P, Zhang T, et al. Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol. 2021;9:811971. doi:10.3389/fbioe.2021.811971
PubMed Web of Science ®Google Scholar
Willms E, Cabañas C, Mäger I, Wood MJA, Vader P. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol. 2018;9:738. doi:10.3389/fimmu.2018.00738
PubMed Web of Science ®Google Scholar
Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961. doi:10.1016/j.addr.2021.113961
PubMed Web of Science ®Google Scholar